Securian Asset Management, Inc Eli Lilly & CO Transaction History

Securian Asset Management, Inc

$3.43 Billion
Q3 2024

A detailed history of Securian Asset Management, Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Securian Asset Management, Inc holds 43,631 shares of LLY stock, worth $32.6 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares

43,631

Previous 45,906 4.96%

Holding current value

$32.6 Million

Previous $41.6 Million 7.0%

% of portfolio

1.13%

Previous 1.22%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$772.14 - $960.02 $1.76 Million - $2.18 Million	-2,275 Reduced 4.96%	43,631 $38.7 Million
Q2 2024 Jul 15, 2024	SELL	$724.87 - $909.04 $769,811 - $965,400	-1,062 Reduced 2.26%	45,906 $41.6 Million
Q1 2024 Apr 26, 2024	SELL	$592.2 - $792.28 $2.11 Million - $2.83 Million	-3,567 Reduced 7.06%	46,968 $36.5 Million
Q4 2023 Feb 08, 2024	SELL	$525.19 - $619.13 $3.51 Million - $4.14 Million	-6,682 Reduced 11.68%	50,535 $29.5 Million
Q3 2023 Oct 30, 2023	SELL	$434.7 - $599.3 $3.89 Million - $5.36 Million	-8,948 Reduced 13.52%	57,217 $30.7 Million
Q2 2023 Aug 07, 2023	SELL	$350.74 - $468.98 $292,517 - $391,129	-834 Reduced 1.24%	66,165 $31 Million
Q1 2023 Apr 27, 2023	BUY	$310.63 - $364.82 $95,363 - $111,999	307 Added 0.46%	66,999 $23 Million
Q4 2022 Feb 02, 2023	SELL	$321.55 - $374.67 $85,210 - $99,287	-265 Reduced 0.4%	66,692 $24.4 Million
Q3 2022 Oct 28, 2022	BUY	$296.48 - $337.87 $71,748 - $81,764	242 Added 0.36%	66,957 $21.7 Million
Q2 2022 Aug 04, 2022	SELL	$278.73 - $327.27 $251,414 - $295,197	-902 Reduced 1.33%	66,715 $21.6 Million
Q1 2022 May 03, 2022	SELL	$234.69 - $291.66 $218,261 - $271,243	-930 Reduced 1.36%	67,617 $19.4 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $149,750 - $185,840	666 Added 0.98%	68,547 $18.9 Million
Q3 2021 Nov 08, 2021	SELL	$221.6 - $272.71 $184,814 - $227,440	-834 Reduced 1.21%	67,881 $15.7 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $76,372 - $98,787	-423 Reduced 0.61%	68,715 $15.8 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $343,264 - $444,372	-2,089 Reduced 2.93%	69,138 $12.9 Million
Q4 2020 Feb 08, 2021	SELL	$130.46 - $172.63 $232,349 - $307,454	-1,781 Reduced 2.44%	71,227 $12 Million
Q3 2020 Nov 04, 2020	SELL	$146.22 - $169.13 $787,248 - $910,595	-5,384 Reduced 6.87%	73,008 $10.8 Million
Q2 2020 Aug 06, 2020	SELL	$136.42 - $164.18 $721,525 - $868,348	-5,289 Reduced 6.32%	78,392 $12.9 Million
Q1 2020 May 07, 2020	SELL	$119.05 - $147.35 $166,908 - $206,584	-1,402 Reduced 1.65%	83,681 $11.6 Million
Q4 2019 Feb 04, 2020	SELL	$106.92 - $132.43 $394,427 - $488,534	-3,689 Reduced 4.16%	85,083 $11.2 Million
Q3 2019 Nov 12, 2019	SELL	$106.79 - $116.16 $241,452 - $262,637	-2,261 Reduced 2.48%	88,772 $9.93 Million
Q2 2019 Aug 05, 2019	BUY	$110.79 - $129.32 $96,498 - $112,637	871 Added 0.97%	91,033 $10.1 Million
Q1 2019 Apr 26, 2019	SELL	$111.31 - $131.02 $849,072 - $999,420	-7,628 Reduced 7.8%	90,162 $11.7 Million
Q4 2018 Feb 04, 2019	BUY	$105.9 - $118.64 $8,895 - $9,965	84 Added 0.09%	97,790 $11.3 Million
Q3 2018 Oct 26, 2018	BUY	$85.86 - $107.31 $15,540 - $19,423	181 Added 0.19%	97,706 $10.5 Million
Q2 2018 Aug 09, 2018	SELL	$75.7 - $86.88 $44,890 - $51,519	-593 Reduced 0.6%	97,525 $8.32 Million
Q1 2018 Apr 30, 2018	SELL	$74.21 - $87.6 $52,689 - $62,195	-710 Reduced 0.72%	98,118 $7.59 Million
Q4 2017 Feb 05, 2018	BUY	$81.94 - $87.89 $68,665 - $73,651	838 Added 0.86%	98,828 $8.35 Million
Q3 2017 Nov 03, 2017	SELL	$77.07 - $85.54 $154 - $171	-2 Reduced -0.0%	97,990 $8.38 Million
Q2 2017 Aug 14, 2017	BUY	N/A	97,992	97,992 $8.07 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Securian Asset Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Securian Asset Management, Inc with notifications on news.

Account

Securian Asset Management, Inc Eli Lilly & CO Transaction History